Doctors test drug doses to stop surgery bleeding
NCT ID NCT03822793
Summary
This study aimed to find the most effective and safe dose of a common drug, tranexamic acid (TXA), to reduce blood loss during and after hip replacement surgery. Researchers tested four different doses against a placebo in 170 patients to see which worked best at preventing severe drops in blood count and the need for blood transfusions. The trial also monitored patients for potential side effects like blood clots.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTHROPATHY OF HIP are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Saint-Etienne
Saint-Etienne, France
Conditions
Explore the condition pages connected to this study.